These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10250785)

  • 1. I.V. prices under new agreements jump 20%.
    Kuntz E
    Mod Healthc; 1981 Apr; 11(4):47-8. PubMed ID: 10250785
    [No Abstract]   [Full Text] [Related]  

  • 2. I.V. prices drop as competition to win key purchasing groups intensifies.
    Fine J
    Mod Healthc; 1986 Jun; 16(13):36. PubMed ID: 10276952
    [No Abstract]   [Full Text] [Related]  

  • 3. Hospitals hold I.V. prices down.
    Kuntz E
    Mod Healthc; 1979 Dec; 9(12):20. PubMed ID: 503017
    [No Abstract]   [Full Text] [Related]  

  • 4. I.V. producers cut prices in fight over contracts.
    Kuntz E
    Mod Healthc; 1979 Apr; 9(4):14. PubMed ID: 154033
    [No Abstract]   [Full Text] [Related]  

  • 5. Hospital supply prices surveyed.
    Purch Adm; 1979 Apr; 3(3):1-2. PubMed ID: 10324003
    [No Abstract]   [Full Text] [Related]  

  • 6. Up to 80% savings on I.V. solutions available to large volume purchasers.
    Johnson DE
    Mod Healthc; 1979 Jan; 9(1):19. PubMed ID: 152847
    [No Abstract]   [Full Text] [Related]  

  • 7. Changing market for sets.
    Hosp Purch Manage; 1986 Feb; 11(2):14-5. PubMed ID: 10275476
    [No Abstract]   [Full Text] [Related]  

  • 8. Revisiting the solution market.
    Hosp Purch Manage; 1981 Jan; 6(1):3-7. PubMed ID: 10249378
    [No Abstract]   [Full Text] [Related]  

  • 9. The problems with solutions.
    Hosp Purch Manage; 1982 Oct; 7(10):12-5. PubMed ID: 10257089
    [No Abstract]   [Full Text] [Related]  

  • 10. Hospitals beat group I.V. prices.
    Kuntz E
    Mod Healthc; 1979 Jul; 9(7):22. PubMed ID: 449851
    [No Abstract]   [Full Text] [Related]  

  • 11. Solutions: Part II--An improved value in a changing market.
    Hosp Purch Manage; 1985 Sep; 10(9):8-10. PubMed ID: 10272702
    [No Abstract]   [Full Text] [Related]  

  • 12. Big discounts mask high profits in solutions market dominated by Travenol and Abbott.
    Hosp Purch Manage; 1978 Oct; 3(10):3-9. PubMed ID: 10238751
    [No Abstract]   [Full Text] [Related]  

  • 13. B-T undercuts group purchase; I.V. war heats up.
    Kuntz E
    Mod Healthc; 1979 Jun; 9(6):12-3. PubMed ID: 440272
    [No Abstract]   [Full Text] [Related]  

  • 14. For-profit and public hospitals get best I.V. prices.
    Kuntz EF
    Mod Healthc; 1981 Sep; 11(9):40-2, 44. PubMed ID: 10252469
    [No Abstract]   [Full Text] [Related]  

  • 15. Hospitals commit to IV contracts.
    Kuntz E
    Mod Healthc; 1980 May; 10(5):45. PubMed ID: 10247353
    [No Abstract]   [Full Text] [Related]  

  • 16. Price survey. I.V. prices expected to stabilize.
    Hosp Mater Manage; 2001 May; 26(5):1, 12-4. PubMed ID: 11357261
    [No Abstract]   [Full Text] [Related]  

  • 17. Prices on i.v. administration sets unstable.
    Brightbill TC
    Hosp Mater Manage; 1987 May; 12(5):3-5. PubMed ID: 10282706
    [No Abstract]   [Full Text] [Related]  

  • 18. Competition closing gap between I.V. prices groups pay.
    Kuntz EF
    Mod Healthc; 1983 Sep; 13(9):78-80. PubMed ID: 10262459
    [No Abstract]   [Full Text] [Related]  

  • 19. I.v. solution prices stabilize.
    Hosp Mater Manage; 1993 Oct; 18(10):1, 13-4. PubMed ID: 10129786
    [No Abstract]   [Full Text] [Related]  

  • 20. Gap closes between prices paid for I.V.s: '82 survey.
    Kuntz EF
    Mod Healthc; 1982 Nov; 12(11):38-9, 42. PubMed ID: 10257212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.